Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study
- 1 November 2018
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 219 (5) , 459.e1-459.e11
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1 U10 CA180822, U10 CA180868, CA 27469, CA 37517)
- National Cancer Institute (1 U10 CA180822, U10 CA180868, CA 27469, CA 37517)
This publication has 31 references indexed in Scilit:
- Endometrial Cancer Risk Factors by 2 Main Histologic SubtypesAmerican Journal of Epidemiology, 2012
- Factors associated with Type I and Type II endometrial cancerCancer Causes & Control, 2010
- Understanding Racial Disparities in Cancer Treatment and OutcomesJournal of the American College of Surgeons, 2010
- FIGO Staging of Endometrial Adenocarcinoma: A Critical Review and ProposalInternational Journal of Gynecological Pathology, 2009
- Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population studyCancer, 2007
- Racial disparities in blacks with gynecologic cancersCancer, 2007
- Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinomaCancer, 2006
- Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United StatesGynecologic Oncology, 2005
- Differences in Treatment and Outcome Between African-American and White Women With Endometrial CancerJournal of Clinical Oncology, 2003
- The National Cancer Data Base report on endometrial carcinoma in African-American womenCancer, 1998